DexCom, Inc. (DXCM)
69.72
-0.53
(-0.75%)
USD |
NASDAQ |
Jan 14, 16:00
69.70
-0.02
(-0.03%)
After-Hours: 18:53
DexCom Market Cap: 27.19B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLife Solutions, Inc. | 1.169B |
| Abbott Laboratories | 217.36B |
| Krystal Biotech, Inc. | 8.465B |
| Boston Scientific Corp. | 138.92B |
| Tandem Diabetes Care, Inc. | 1.415B |
Market Cap Related Metrics
| PE Ratio | 38.80 |
| PS Ratio | 6.291 |
| PEG Ratio | 5.033 |
| Price to Book Value | 9.975 |
| Price to Free Cash Flow | 26.75 |
| Price | 69.72 |
| Earnings Yield | 2.58% |
| PEGY Ratio | 5.033 |
| Operating PE Ratio | 36.53 |
| Normalized PE Ratio | 38.80 |